Topic taxonomy suggestions experiment

Efanesoctocog alfa approved to prevent and treat bleeding in children and adults with severe or moderate haemophilia A

View document on GOV.UK (opens in new tab)

Existing topic taxonomy tags

Tags already associated with the document.

Suggested topic taxonomy tags

Tags which are used on similar documents.

Similar documents

The documents from which the suggested topic taxonomy tags are derived.

1. Marstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with haemophilia A or B
2. Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors
3. MHRA approves sebetralstat (Ekterly) to treat hereditary angioedema (HAE) attacks in patients aged 12 and over
4. MHRA approves first UK treatment for congenital thrombotic thrombocytopenic purpura (cTTP) 
5. Garadacimab (andembry) approved to prevent angioedema attacks